Intellectual Property

Owen Mumford is a global leader in medical device design and manufacturing.

Insights from our customers and clinical specialists drive us to continuously explore ways to improve our existing product range and extend our product portfolio. As part of our new product development process, we develop and acquire new technologies which enable us to create innovative product and design solutions. This process generates intellectual property which is utilised throughout our product range.

Intellectual property rights such as copyright, design rights, trade marks, patents etc. available on the owenmumford.com website remain the property of Owen Mumford (or as the case may be another rightful owner).

This page is intended to serve as notice of all current intellectual property rights owned by Owen Mumford or licensed to Owen Mumford.

Licensed patent family:

Ateria SafeControl

The following pending patent applications or granted patents apply to this product:

GB2532983B, CN107073228A, US2018/221591A, and

EP3174582B1 (validated in France, Germany, Italy, Spain, Sweden and the United Kingdom).

GB2537441B, GB2552901A, CN106139329A, CN206325077U, JP2018515150A, KR101861978B, MX2017003305A, TWI649107B, US2018/064883A, and

EP3193989B (validated in Czech Republic, Denmark, France, Germany, Hungary, Ireland, Italy, Poland, Slovakia, Sweden, Switzerland and the United Kingdom).

The following registered designs or design patents apply to this product:

European Registered Community Design 3337856-0001 to 3337856-0027, CN304112706 S, CN304176972 S, CN304206697 S, CN304206698 S, CN304206699 S, CN304152270 S, CN304152271 S, IN290775, IN290776, IN290777, JP1611123, JP1611124, KR3009505980001, KR3009505980002, KR3009505980003.

 

Date of last update: 29/08/2019